Malaysia

Non-communicable diseases such as cardiovascular disease, cancer, diabetes, mental health disorders and obesity, have emerged as leading causes of death among Malaysia’s population of 32.6 million. 

As part of a plan to improve its healthcare system, the Ministry of Health in 2020 launched its Strategic Framework of the Medical Programme 2021 - 2025 as a guide to achieving universal health coverage, with a particular focus on tackling mental health and cancer treatment.

Since the start of the pandemic, Roche Diagnostics tested more than 500,000 patients with our tests, including supplying rapid antigen tests for regular screening of workers in high-risk areas such as factories. 

We also set up more than 10 testing labs in the public and private sector, and supplemented labs with more than a million COVID tests as demand soared.

Expanding Sustainable Cancer Care

• To improve cancer care infrastructure and improve the lives of these patients, we supported key local organisations in their efforts to win Greater Petaling’s bid to join the City Cancer Challenge.
• As a strategic partner, we aim to collaborate with key stakeholders to close gaps in cancer care services, improve access to sustainable cancer treatments and deliver locally-led, sustainable care solutions.

Removing obstacles to Cervical Cancer screening

• To expand testing access to more eligible women, we supported a program to increase cervical cancer screening rates. We supplied the ROSE lab with a HPV testing system, and the women with self-sampling kits.

Faster diagnostics, better education to tackle heart failure

• To improve heart failure diagnosis rates, we reached over 300 healthcare professionals on topics including heart condition diagnosis tests and clinical practice guidelines.
• We also ran a patient access programme in collaboration with partner pharmaceutical companies to increase the access to natriuretic peptide tests, benefitting over 400 patients in total.